William Michael Kavanaugh
8Patents
3h-index
10Co-inventors
54Inventor score
Filing activity: Dec 9, 1994 → Oct 12, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6280964A | Binding sites for phosphotyrosine binding domains | Emerging Cross-Sectional Technologies | 25 | Expired |
| US5744313A | Assay employing novel protein domain which binds tyrosine phosphorylated proteins | Human Necessities | 6 | Expired |
| US8652469B2 | M-CSF-specific monoclonal antibody and uses thereof | Chemistry; Metallurgy | 5 | Active |
| US5925547A | Nucleic acid encoding novel protein domain which binds tyrosine phosphorylated proteins | Human Necessities | 3 | Expired |
| US9926371B2 | M-CSF specific monoclonal antibody and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US9079956B2 | M-CSF specific monoclonal antibody and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US9522186B2 | M-CSF specific monoclonal antibody and uses therof | Chemistry; Metallurgy | 1 | Active |
| US11034759B2 | Humanized M-CSF specific monoclonal antibodies, kits, and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.